Estrella Immunopharma (ESLAW) Stock Chart & Stock Price History $0.06 +0.00 (+7.49%) As of 06/13/2025 03:57 PM Eastern Add Compare Share Share Chart Stock AnalysisChartCompetitorsSEC FilingsTrendsBuy This Stock Estrella Immunopharma Stock Price Performance The Estrella Immunopharma (ESLAW) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has increased 58.13%, with a year-to-date return of -37.54%. In the past month, the stock has decreased 15.59%, reflecting recent market activity. As of the latest close, Estrella Immunopharma traded at $0.06 with a market cap of and volume of 14,794 shares. Receive ESLAW Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Estrella Immunopharma and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance+17.14%1 Month Performance-15.59%3 Month Performance-36.22%Year-To-Date Performance-37.54%1 Year Performance+58.13% ESLAW Stock Chart for Saturday, June, 14, 2025 ESLAW Chart by TradingView Estrella Immunopharma Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization06/13/2025$0.05$0.06+7.49%$0.06$0.0514,794 shs$0.0006/12/2025$0.04$0.05+42.40%$0.05$0.03107,153 shs$0.0006/11/2025$0.05$0.04-23.47%$0.07$0.0418,429 shs$0.0006/10/2025$0.05$0.05$0.08$0.0415,700 shs$0.0006/09/2025$0.05$0.05-5.41%$0.08$0.0415,769 shs$0.0006/06/2025$0.04$0.05+29.18%$0.08$0.0434,188 shs$0.0006/05/2025$0.04$0.04+0.25%$0.04$0.0415,716 shs$0.0006/04/2025$0.04$0.04-0.25%$0.04$0.045,000 shs$0.0006/03/2025$0.04$0.04-5.87%$0.06$0.0416,248 shs$0.0006/02/2025$0.04$0.04+19.33%$0.04$0.041,655 shs$0.00 Get the Latest News and Ratings for ESLAW and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Estrella Immunopharma and its competitors with MarketBeat's FREE daily newsletter. 05/30/2025$0.04$0.04$0.04$0.04100 shs$0.0005/29/2025$0.05$0.04-21.02%$0.04$0.04170 shs$0.0005/28/2025$0.05$0.05+0.22%$0.07$0.052,062 shs$0.0005/27/2025$0.04$0.05+24.93%$0.05$0.052 shs$0.0005/26/2025$0.04$0.04$0.04$0.04200 shs$0.0005/23/2025$0.04$0.04-10.42%$0.04$0.04200 shs$0.0005/22/2025$0.04$0.04+0.75%$0.06$0.0455,988 shs$0.0005/21/2025$0.04$0.04-5.88%$0.08$0.0427,707 shs$0.0005/20/2025$0.06$0.04-28.45%$0.09$0.0414,571 shs$0.0005/19/2025$0.06$0.06$0.06$0.06606 shs$0.0005/16/2025$0.06$0.06-1.00%$0.06$0.06606 shs$0.0005/15/2025$0.07$0.06-11.76%$0.07$0.062,202 shs$0.0005/14/2025$0.07$0.07$0.07$0.07273 shs$0.0005/13/2025$0.08$0.07-18.95%$0.07$0.07273 shs$0.00 Related Companies 180 Life Sciences Stock Chart 60 Degrees Pharmaceuticals Stock Chart Alpha Tau Medical Stock Chart Apollomics Stock Chart BriaCell Therapeutics Stock Chart Cardio Diagnostics Stock Chart Carmell Stock Chart Celularity Stock Chart CERo Therapeutics Stock Chart Cingulate Stock Chart Receive ESLAW Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Estrella Immunopharma and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:ESLAW) was last updated on 6/14/2025 by MarketBeat.com Staff From Our PartnersThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredAn AI run of epic proportions is only getting startedI just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredIs Elon's empire crumbling?The Tesla Shock Nobody Sees Coming While headlines scream "Tesla is doomed"... Jeff Brown has uncovered ...Brownstone Research | SponsoredOil Hits $74 - $100 Next?Oil Jumps 8.5% on Middle East Crisis Trump at Oil Fields Oil surged 8.5% to $74/barrel after Israel's Ir...The Oxford Club | Sponsored[First Look] Get in before potential 10X AI announcementsGo for 10X gains from the next big AI announcement — starting as soon as 7 days from now Former floor trade...Masters in Trading | SponsoredBig Changes Coming to Social Security?According to legendary investor Louis Navellier... This new Trump move could soon not only save Social Secu...InvestorPlace | SponsoredAs Bitcoin supply vanishes, this Trump-aligned token could explodeBitcoin's supply is being drained at unprecedented rates, but while most investors focus solely on Bitcoin, th...Crypto 101 Media | SponsoredThink you missed gold’s boom? Think againIf you've been watching gold's historic run and wondering if it's too late… I've got good news. Because the...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Estrella Immunopharma, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Estrella Immunopharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.